Skip to main content

Table 3 Baseline characteristics of study participants in the 183 included articles

From: A systematic review of biomarkers for disease progression in Parkinson’s disease

 

All studies (n=183)

Longitudinal studies (n=20)

Cross-sectional studies (n=163)

P value

Baseline demographics

       

  Median number of patients

32

(21 to 53)

31

(16 to 36)

34

(22 to 55)

0.058

  Mean age (years)

63.5

(5.6)

63.7

(6.7)

63.4

(5.5)

0.771

  Mean percentage male

58.7

(13.9)

67.3

(15.6)

57.7

(13.3)

0.002

  Median disease duration (years)

5.7

(3.6 to 7.4)

3.2

(1.7 to 5.9)

5.9

(4.1 to 7.6)

0.005

  Median percentage treated

76.8

(51.2 to 88.8)

40.6

(0.0 to 71.1)

78.5

(56.7 to 90.2)

0.005

Baseline disease severity

       

  Median total UPDRS

33.3

(29.4 to 40.6)

31.8

(30.1 to 38.7)

33.3

(29.4 to 40.6)

0.790

  Median UPDRS (II)

14.7

(11.6 to 16.3)

9.1

(Insufficient data for IQR)

14.8

(11.9 to 16.6)

0.023

  Median UPDRS (III)

21.0

(16.6 to 26.3)

22.4

(16.3 to 28.5)

20.9

(16.8 to 25.8)

0.864

  Median Hoehn & Yahr

2.5

(2.0 to 2.8)

1.8

(1.6 to 2.0)

2.5

(2.1 to 2.9)

<0.001

  Median MMSE

25.8

(23.0 to 28.1)

25.5

(22.3 to 28.3)

25.8

(23.0 to 28.1)

1.000

  1. Means are presented with standard deviations, and medians with interquartile ranges (IQR). The P value column relates to comparisons made between longitudinal and cross-sectional studies using the Mann–Whitney test.